LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 1 of 15: Cell count and relative growth within biological replicate 1. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 1 of 15: Cell count and relative growth within biological replicate 1. - Dataset (ID:20237)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells

|<
<<
Previous
Page 257 of 497
Next
>>
>
6401 to 6425 of 12420 records
per page:

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Replicate	Assay Well	Timepoint	Timepoint Unit	Total Cell Count Before Treatment	Total Cell Count After Treatment	Total Control Cell Count	Relative Cell Count	Relative Growth Rate After Treatment
MCF7	Linifanib	0.04	uM	LJP6	2	J12	72	hr	1235	4725	4156	1.1369	1.1948
MCF7	Linifanib	0.04	uM	LJP6	3	J12	72	hr	1235	4806	4156	1.1564	1.2225
MCF7	Linsitinib	0.04	uM	LJP5	1	O24	72	hr	1235	2970	4156	0.7146	0.5939
MCF7	Linsitinib	0.04	uM	LJP5	2	O24	72	hr	1235	3703	4156	0.8910	0.8449
MCF7	Linsitinib	0.04	uM	LJP5	3	O24	72	hr	1235	3058	4156	0.7358	0.6240
MCF7	Mitoxantrone	0.04	uM	LJP5	1	C24	72	hr	1235	1271	4156	0.3058	0.0122
MCF7	Mitoxantrone	0.04	uM	LJP5	2	C24	72	hr	1235	1302	4156	0.3133	0.0228
MCF7	Mitoxantrone	0.04	uM	LJP5	3	C24	72	hr	1235	1569	4156	0.3775	0.1142
MCF7	Mitoxantrone	0.04	uM	LJP6	1	C24	72	hr	1235	1106	4156	0.2661	-0.0443
MCF7	Mitoxantrone	0.04	uM	LJP6	2	C24	72	hr	1235	1223	4156	0.2943	-0.0042
MCF7	Mitoxantrone	0.04	uM	LJP6	3	C24	72	hr	1235	1182	4156	0.2844	-0.0183
MCF7	MK2206	0.04	uM	LJP6	1	F06	72	hr	1235	2598	4156	0.6251	0.4665
MCF7	MK2206	0.04	uM	LJP6	2	F06	72	hr	1235	2966	4156	0.7136	0.5925
MCF7	MK2206	0.04	uM	LJP6	3	F06	72	hr	1235	3001	4156	0.7221	0.6045
MCF7	Neratinib	0.04	uM	LJP5	1	A18	72	hr	1235	3027	4156	0.7283	0.6134
MCF7	Neratinib	0.04	uM	LJP5	2	A18	72	hr	1235	3202	4156	0.7704	0.6733
MCF7	Neratinib	0.04	uM	LJP5	3	A18	72	hr	1235	3393	4156	0.8164	0.7387
MCF7	Nilotinib	0.04	uM	LJP5	1	N18	72	hr	1235	4323	4156	1.0401	1.0571
MCF7	Nilotinib	0.04	uM	LJP5	2	N18	72	hr	1235	4671	4156	1.1239	1.1763
MCF7	Nilotinib	0.04	uM	LJP5	3	N18	72	hr	1235	4390	4156	1.0563	1.0801
MCF7	Nintedanib	0.04	uM	LJP6	1	H06	72	hr	1235	4332	4156	1.0423	1.0602
MCF7	Nintedanib	0.04	uM	LJP6	2	H06	72	hr	1235	3536	4156	0.8508	0.7877
MCF7	Nintedanib	0.04	uM	LJP6	3	H06	72	hr	1235	4129	4156	0.9935	0.9907
MCF7	NU7441	0.04	uM	LJP5	1	C12	72	hr	1235	4250	4156	1.0226	1.0321
MCF7	NU7441	0.04	uM	LJP5	2	C12	72	hr	1235	4174	4156	1.0043	1.0061

|<
<<
Previous
Page 257 of 497
Next
>>
>
6401 to 6425 of 12420 records
per page:

HMS LINCS Project

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 1 of 15: Cell count and relative growth within biological replicate 1. - Dataset (ID:20237)